Dr Jennifer Guy MD MAS is a transplant hepatologist and Director of the Liver Cancer Program at California Pacific Medical Center. She is the Kranzusch Bosworth Endowed Chair for Innovation in Transplant Medicine with a focus on optimizing the patient experience.
Rotonya McCants Carr, MD is the Cyrus E. Rubin Chair and Division Head of Gastroenterology at the University of Washington. She is a basic science researcher and clinical hepatologist who specializes in the care of patients with fatty liver diseases. Her laboratory uses complementary in vivo and cellular approaches to investigate the mechanisms of insulin resistance in metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD) and alcohol-associated liver disease (ALD). Dr.
Teresa (Terry) Wright is currently Vice President for Clinical Research Infectious Diseases at Vir Biotechnology with responsibility for oversight of clinical development of investigational agents for patients with viral liver diseases.
Dr. Lok graduated from the University of Hong Kong Medical School. She completed her hepatology training in London under Dame Sheila Sherlock. She was on the faculty at the University of Hong Kong until she moved to the United States in 1992.
Dr. Lok's research focuses on natural history and treatment of hepatitis B and C. She has published more than 650 papers.
H. Marvin Pollard Collegiate Professor of Gastroenterology III
Professor of Internal Medicine and Surgery
Director, Morphomics Analysis Group
University of Michigan Medical School
Chief, Gastroenterology and Hepatology Section
Associate Chief of Specialty Care and Access, Medicine Service
VA Ann Arbor Healthcare System
I happily wear the label of physician-scientist and am on the faculty of Keck Medicine of the University of Southern California. Rather than describing myself, I would rather tell you about some of our research. Since my Fellowship, my basic science has focused on the liver sinusoidal endothelial cell, the LSEC.
Grace Wong is the Professor of The Chinese University of Hong Kong. She graduated from the Chinese University of Hong Kong in 2001 with honors and distinctions in Medicine. In 2010, she received the Doctoral Degree of Medicine of the Chinese University of Hong Kong.
I am a transplant hepatologist at the University of North Carolina in Chapel Hill. I have a special interest in alcohol-related liver disease, and I am the Director of UNC's Integrated Healthcare for Alcohol Use and Liver Disease (IHEAL) Clinic. I am active in AASLD through my work as a co-founder of Liver Fellow Network and currently as Chair of AASLD's Practice Metrics Committee.
Richard Jaenisch, MPH is a patient advocate for liver transplantation, and HCV. As a survivor and caregiver, he extends his lived experience to his work at both Open Biopharma Research and Training Institute and Prompting Integration and Consulting LLC. Richard has always been involved in the digital patient experience from online moderation of forums, content creation and being a patient stakeholder, this is continued this by expanding his area of advocacy to include work in data and artificial intelligence.